Section one: Contracting authority
one.1) Name and addresses
HEALTH DATA RESEARCH UK
215 Euston Road
LONDON
NW12BE
Country
United Kingdom
Region code
UKI31 - Camden and City of London
Charity Commission (England and Wales)
1194431
Internet address(es)
Main address
one.1) Name and addresses
UK DRI LTD
338 Euston Road
London
NW1 3BT
Country
United Kingdom
Region code
UKI31 - Camden and City of London
Charity Commission (England and Wales)
1179589
Internet address(es)
Main address
one.2) Information about joint procurement
The contract involves joint procurement
one.3) Communication
Access to the procurement documents is restricted. Further information can be obtained at
https://www.hdruk.ac.uk/jobs/brain-health-clinical-trials-data-augmentation-service/
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://www.hdruk.ac.uk/jobs/brain-health-clinical-trials-data-augmentation-service/
one.4) Type of the contracting authority
Other type
Charity in receipt of public funding
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Brain Health Community Assessment for Trials Service
Reference number
HDRUK2024.0413
two.1.2) Main CPV code
- 85323000 - Community health services
two.1.3) Type of contract
Services
two.1.4) Short description
Health Data Research UK (HDR UK) and UK Dementia Research Institute (UK DRI) are working in partnership to deliver the Dementia Trials Accelerator (DTA). The DTA, supporting the Government's Dame Barbara Windsor Dementia Goals programme and funded by the Medical Research Council (MRC), aims to rapidly identify a large group of people who are at risk of, or diagnosed with, early-stage dementia. This will boost opportunities for these people to participate in clinical trials, improve research inclusion and reduce the high screening failure rates currently observed in dementia trials.
two.1.5) Estimated total value
Value excluding VAT: £2,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 73110000 - Research services
- 73210000 - Research consultancy services
- 75122000 - Administrative healthcare services
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
Programme Vision:
The DTA vision is for the UK to become the destination of choice for late-phase clinical trials in dementia and neurodegenerative diseases. The aims of the DTA are to:
1. Increase trial recruitment by identifying potential participants in trials by creating a "biomarker toolbox". This toolbox will incorporate one or more of: genetic or clinical risk scores, blood-based biomarkers and clinical measurements of subjects living with or at risk of dementia and related neurodegenerative disorders
2. Work with existing UK patient or population cohorts to approach people for clinical trials to identify potential participants
3. Accelerate low-cost delivery identification of potential participants in dementia and neurodegenerative trials with community-based, digitally enabled, trial pre-screening
4. Accelerate collaborative neurodegenerative research through assembly of a secure UK-wide AI-enabled data platform that makes multi-dimensional FAIR (findable, accessible, interoperable, reusable) through trustworthy and secure data environment(s)
5. Prioritise the needs of industry innovators, patients and the public with an iterative engagement with stakeholders
Service Required:
Brain Health Community Assessment for Trials Service is central to this vision. It will provide pre-screening for a range of dementia and neurodegenerative clinical trials close to where people live as recommended by the O'Shaughnessy Review. The appointed provider will deliver comprehensive services, including:
1. Appointment booking system that enables participants to book appointments directly through a portal;
2. Booking system able to receive information from and interface via secure integration with data partners;
3. Telephone and email support with appointment booking if needed by participants;
4. Identity check and verifying or obtaining informed consent;
5. Complete 10,000 appointments - one appointment per participant to deliver;
• community phlebotomy service;
• digital cognitive and 'day-to-day function' assessment performed using electronic device in a quiet location;
• physical measurements: height, weight, blood pressure;
6. Blood sample processing;
7. Sample storage, tracking and shipment to a chosen UK location(s)
8. Data collection, storage and sharing.
The service required will be a pilot with appointments across England, with plans to expand to underserved areas. The aim is to identify up to 10,000 potential trial participants over one year.
Providers must ensure accessibility and provide flexible service times which accommodates those who have daytime commitments. They must also comply with regulatory standards for sample handling, participant confidentiality, and data security.
This procurement marks the first phase of a broader initiative, future phases of which will include coverage of the four nations of the UK, subject to a separate procurement process.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £2,000,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
18
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2024/S 000-039398
four.2.2) Time limit for receipt of tenders or requests to participate
Date
14 April 2025
Local time
1:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
14 April 2025
Local time
2:00pm
Information about authorised persons and opening procedure
The Authorities do not have use of a tendering portal for this procurement, or sufficient controls for receipt of physical tenders via post.
Tenders are to be submitted via email, contained within a single .zip folder attachment, and password protected (locked). Only locked Tenders received via email will be accepted. Passwords must not be provided to the Authorities prior to the submission deadline.
Only locked Tenders received via email by the submission deadline will be accepted. After the deadline, the Authorities will log received locked Tenders and contact Tenderers via email to request passwords. These must be supplied promptly upon request, but not prior to the deadline. This will ensure that the Authorities will not be able to access or open Tenders before the deadline.
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
Public Procurement Review Service (Cabinet Office)
London
Country
United Kingdom